Surgalign Holdings logo
Surgalign Holdings SRGA
report update icon

Quarterly report 2023-Q1
added 05-30-2026

Surgalign Holdings Cash Flow 2022-2011 | SRGA

Brief overview of Surgalign Holdings's cash generation

Cash flow changes are traced through the five latest available reports from 2018 to 2022.

At the end of the period, operations consumed -$52.1 million rather than generating cash. This profile calls for caution.

Positive operating cash flow appeared only 1 times out of five; a stable cash profile has not formed.

Operating cash flow margin declined from 18.7% to -63.6%. Revenue converted into cash less effectively.

Overall assessment

Taken together, Surgalign Holdings's cash flow indicators point to increased dependence on reserves or outside financing.

Annual Cash Flow Surgalign Holdings

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Operating Cash Flow

-52.1 M -51.8 M -88 M -9.46 M 17.3 M 5.79 M 15.3 M - - - - -

Depreciation & Amortization

2.18 M 2.48 M 6.58 M 22.7 M 14.6 M 14.2 M 16.5 M - - - - -

Accounts Payables

7.7 M 10.2 M 13.4 M 10.2 M 7.56 M 18.2 M 26.1 M - - - - -

Accounts Receivables

16.1 M 19.2 M 27.1 M 23.2 M 16.8 M 38.4 M 40.9 M - - - - -

Total Inventories

17.7 M 26.2 M 22.8 M 24.6 M 19.1 M 112 M 120 M - - - - -

All numbers in USD currency

Quarterly Cash Flow Surgalign Holdings

2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Operating Cash Flow

-9.02 M - -45.8 M -32.4 M -19.1 M - -41.6 M -46.1 M -14.5 M - -72.7 M -14.6 M 6.52 M - -12.7 M -13.1 M -15.7 M - 11 M 9.38 M -1.09 M - - - 9.58 M - - - 6.42 M - - - - - - - - - - - - - - - - - - - -

Depreciation & Amortization

499 K - 1.73 M 1.18 M 562 K - 1.86 M 1.15 M 520 K - 6 M 4.69 M 2.24 M - 11.4 M 7.49 M 3.7 M - 10.8 M 7.07 M 3.58 M - - - 3.57 M - - - 4.31 M - - - - - - - - - - - - - - - - - - - -

Accounts Payables

7.49 M 7.7 M 13.1 M 10.6 M 12.1 M 10.2 M 9.48 M 9.58 M 13.1 M 13.4 M 10.8 M 37.5 M 38.5 M 10.2 M 17.8 M 20.8 M 23.3 M 7.56 M 26.3 M 26.3 M 26.3 M 18.2 M 24.4 M 27.7 M 28.3 M 26.1 M 23.3 M 25.8 M 24.3 M - - - - - - - - - - - - - - - - - - - -

Accounts Receivables

12.6 M 16.1 M 18.9 M 20.5 M 20.5 M 19.2 M 20.7 M 30.5 M 29.3 M 27.1 M 24.5 M 46.9 M 54.9 M 23.2 M 56.6 M 56.2 M 55.7 M 16.8 M 48.4 M 48.4 M 48.4 M 38.4 M 36 M 38.4 M 36.2 M 40.9 M 37.3 M 36.1 M 38.6 M - - - - - - - - - - - - - - - - - - - -

Total Inventories

13.5 M 17.7 M 22.7 M 25.3 M 23 M 26.2 M 27.4 M 26.5 M 22.9 M 22.8 M 28.2 M 123 M 127 M 24.6 M 131 M 128 M 114 M 19.1 M 107 M 107 M 107 M 112 M 115 M 117 M 118 M 120 M 125 M 122 M 124 M - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Cash Flow Statement is one of the three key financial reports of the company Surgalign Holdings, reflecting the actual cash inflows and outflows over a certain period. Unlike the income statement, which shows revenues and expenses on an accrual basis, the cash flow statement focuses on real cash flows — how much cash actually came into the company and how much was spent.

Main Sections of the Cash Flow Statement
  • Operating Activities
    This section reflects cash flows related to the company’s core operations: receipts from sales of goods and services, payments to suppliers, employee salaries, taxes, and other operating expenses. Positive cash flow from operating activities indicates the viability of the business and its ability to generate cash.
  • Investing Activities
    Shows cash movements related to the purchase and sale of long-term assets such as real estate, equipment, and investments in other companies. Negative cash flow here often indicates investments in growth, which can be a positive sign.
  • Financing Activities
    Reflects the inflow and outflow of cash related to raising and repaying capital: issuing shares, loans, dividend payments, and loan repayments. This section shows how the company finances its activities and distributes profits.

The cash flow statement is important for investors because it allows them to assess the company’s real liquidity, showing whether it has enough cash to cover current obligations and investments — this is critical for financial stability. Additionally, it helps analyze the quality of earnings, since profits reported in the income statement can be "paper" profits and may not reflect actual cash inflows; the cash flow statement reveals this difference. The presence of free cash is also crucial for evaluating the company’s ability to finance growth and pay dividends, which is important for investors. Attention should also be paid to prolonged negative cash flows from operating activities, as this may serve as a warning sign of potential problems with the core business.

Cash flow statements of other stocks in the Medical devices sector

Issuer Price % 24h Market Cap Country
AxoGen AxoGen
AXGN
$ 43.32 0.04 % $ 1.99 B usaUSA
Bruker Corporation Bruker Corporation
BRKR
$ 59.67 0.18 % $ 9.06 B usaUSA
Cognyte Software Ltd. Cognyte Software Ltd.
CGNT
$ 8.73 1.16 % $ 637 M israelIsrael
ClearPoint Neuro ClearPoint Neuro
CLPT
$ 14.97 13.03 % $ 424 M usaUSA
Conformis Conformis
CFMS
- - $ 16.4 M usaUSA
CONMED Corporation CONMED Corporation
CNMD
$ 45.8 3.31 % $ 1.42 B usaUSA
Cytosorbents Corporation Cytosorbents Corporation
CTSO
$ 4.91 0.75 % $ 306 M usaUSA
Delcath Systems Delcath Systems
DCTH
$ 15.96 1.8 % $ 572 M usaUSA
Eargo Eargo
EAR
- - $ 10.2 M usaUSA
AdaptHealth Corp. AdaptHealth Corp.
AHCO
$ 5.7 0.43 % $ 770 M usaUSA
Electromed Electromed
ELMD
$ 27.57 0.11 % $ 228 M usaUSA
Establishment Labs Holdings Establishment Labs Holdings
ESTA
$ 67.76 3.69 % $ 2.01 B costa-ricaCosta-rica
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
EW
$ 86.82 0.51 % $ 50.8 B usaUSA
Align Technology Align Technology
ALGN
$ 148.17 4.36 % $ 10.7 B usaUSA
Helius Medical Technologies Helius Medical Technologies
HSDT
$ 2.88 2.45 % $ 63.5 M usaUSA
Integra LifeSciences Holdings Corporation Integra LifeSciences Holdings Corporation
IART
$ 15.53 2.76 % $ 1.19 B usaUSA
Inogen Inogen
INGN
$ 5.09 2.55 % $ 135 M usaUSA
Inspire Medical Systems Inspire Medical Systems
INSP
$ 69.06 0.57 % $ 2.03 B usaUSA
IRIDEX Corporation IRIDEX Corporation
IRIX
$ 0.63 0.08 % $ 10.7 M usaUSA
IRadimed Corporation IRadimed Corporation
IRMD
$ 86.35 0.08 % $ 1.1 B usaUSA
Integer Holdings Corporation Integer Holdings Corporation
ITGR
$ 126.32 0.02 % $ 4.39 B usaUSA
LENSAR LENSAR
LNSR
$ 7.15 0.14 % $ 85.5 M usaUSA
Medigus Ltd. Medigus Ltd.
MDGS
- 10.28 % $ 55.5 M israelIsrael
Apyx Medical Corporation Apyx Medical Corporation
APYX
$ 2.95 1.37 % $ 121 M usaUSA
Cutera Cutera
CUTR
- -10.19 % $ 1.99 M usaUSA
Medtronic PLC Medtronic PLC
MDT
$ 89.3 0.08 % $ 114 B usaUSA
MiMedx Group MiMedx Group
MDXG
$ 4.77 0.2 % $ 705 M usaUSA
Accuray Incorporated Accuray Incorporated
ARAY
$ 0.23 1.0 % $ 28.2 M usaUSA
Myomo Myomo
MYO
$ 1.64 0.3 % $ 68.6 M usaUSA
Nano-X Imaging Ltd. Nano-X Imaging Ltd.
NNOX
$ 0.7 0.45 % $ 45.4 M israelIsrael
Nemaura Medical Nemaura Medical
NMRD
- -17.8 % $ 2.74 M britainBritain
InspireMD InspireMD
NSPR
$ 0.74 0.16 % $ 47.6 M israelIsrael
Orthofix Medical Orthofix Medical
OFIX
$ 9.18 2.23 % $ 364 M curacaoCuracao
Outset Medical Outset Medical
OM
$ 3.09 5.45 % $ 47 K usaUSA
Boston Scientific Corporation Boston Scientific Corporation
BSX
$ 44.62 0.31 % $ 66.1 B usaUSA
Insulet Corporation Insulet Corporation
PODD
$ 136.49 0.01 % $ 9.6 B usaUSA
Profound Medical Corp. Profound Medical Corp.
PROF
$ 5.74 0.16 % $ 174 M canadaCanada
Quanterix Corporation Quanterix Corporation
QTRX
$ 3.16 4.93 % $ 135 M usaUSA
AVITA Medical AVITA Medical
RCEL
$ 10.95 0.61 % $ 305 M australiaAustralia
Neovasc Neovasc
NVCN
- - $ 111 M canadaCanada
Sintx Technologies Sintx Technologies
SINT
$ 1.78 3.98 % $ 4.94 M usaUSA
Smith & Nephew plc Smith & Nephew plc
SNN
$ 26.82 0.07 % $ 23.3 B britainBritain
Inari Medical Inari Medical
NARI
- - $ 4.23 B usaUSA
Sensus Healthcare Sensus Healthcare
SRTS
$ 3.03 0.32 % $ 49.5 M usaUSA
Stryker Corporation Stryker Corporation
SYK
$ 273.4 0.38 % $ 104 B usaUSA
Tactile Systems Technology Tactile Systems Technology
TCMD
$ 22.43 0.55 % $ 513 M usaUSA
TELA Bio TELA Bio
TELA
$ 1.3 0.71 % $ 61 M usaUSA
Viemed Healthcare Viemed Healthcare
VMD
$ 8.8 1.24 % $ 342 M usaUSA
Varex Imaging Corporation Varex Imaging Corporation
VREX
$ 18.45 0.05 % $ 764 M usaUSA
Sientra Sientra
SIEN
- -16.59 % $ 10.3 M usaUSA